GL1X · GenesisL1 explorer

MolNFT v1 · #159086 · protein

Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects

6OE1 · Carbonic anhydrase 2: “Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II…”. X-ray diffraction, 3 ligands (M8V, ZN, SO4), 1 pocket (best druggability 0.59). MolNFT v1 #159086…

PDB
6OE1
Type
protein
Length
258 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbonic anhydrase 2
EC
4.2.1.1
UniProt
P00918
Ligands
M8V, ZN, SO4
Pockets
1 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarbonic anhydrase 2 (EC 4.2.1.1)protein25815% helix, 30% strandP00918

Ligands and binding sites

  • M8V · 2-(2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl)-N-(4-sulfamoylphenyl)acetamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11880.590.8127GOL, M8V

Compared structures

  • 6OE1 · Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00918 · AlphaFold monomer V2.0 prediction for carbonic anhydrase 2 (P00918) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.